HIV news from aidsmap.com

Modelling study backs targeted, not universal, lenacapavir PrEP for pregnancy and breastfeeding
Targeted deployment of twice-yearly lenacapavir for pregnant and breastfeeding women without HIV in high-incidence districts in sub-Saharan Africa could substantially reduce vertical transmission at a fraction of the cost of universal rollout, according to a modelling study published in the Journal of the International AIDS Society. But the authors say lenacapavir should be seen as complementary to, not a substitute for, strengthening existing programmes to prevent vertical transmission.
>> Read more

Kaposi sarcoma claims lives of South Africans with HIV, despite the ART rollout
Patients with Kaposi sarcoma (KS) in South Africa are presenting late to healthcare facilities and have an overall poor prognosis, despite the decade-long rollout of antiretroviral therapy (ART), according to a new study. KS is a cancer caused by the human herpes virus 8 (HHV-8) and usually appears as lesions on the skin or on mucosal surfaces, like inside the mouth or in the genital area.
>> Read more

Worse HIV control at diagnosis doesn't mean worse lymphoma outcomes
The outcomes of lymphoma – one of the most common types of cancer in people with HIV – seem to be largely uninfluenced by viral suppression at the time of diagnosis. Although people with detectable viral load had lower CD4 counts and more advanced lymphoma when diagnosed, their chances of remission and survival were similar to those of people whose HIV was suppressed.
>> Read more